Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspective

• Published in: Life sciences (1973) Vol. 301; p. 120637
• Main Authors: Patil, Prasanna J., Sutar, Shubham S., Usman, Muhammad, Patil, Devashree N., Dhanavade, Maruti J., Shehzad, Qayyum, Mehmood, Arshad, Shah, Haroon, Teng, Chao, Zhang, Chengnan, Li, Xiuting
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 15.07.2022; Elsevier BV
• Subjects: Anti-cancer; Anti-CoVID-19; Anticancer properties; Aptamers; Bioactive peptides; Biological activity; Biotechnology; Cancer; consumer acceptance; Coronaviruses; COVID-19; COVID-19 infection; disease control; Intestinal microflora; intestinal microorganisms; Medical research; Microbiota; Neurodegenerative diseases; Neuroprotection; Next-generation approaches; Peptides; therapeutics; PEU; TNFα; BBB; KTN; ADNF; mHTT; MERS-CoV; BMP-2; MPP; AP-1; RBD; BCM-7; Aib; RAFT; RBM; AD; IL-6; ACBPs; AQ; POEGMA-PHPMA; OGlcNAc; CE-SELEX; hCMCs; GLP-1R; Neuroprotection; TPE; FDM; hACE2; BR; PLLD; AAs; SF; E-PB; AChE; PEGDA; HAH; 3D; Cdk5; OGP; MPTP; TP; CNT-PLLA; AEGIS-SELEX; AFM-SELEX; TAT; ALS; MTT; IFN-α; Aβ; cyO8; NF-κB; SARS-CoV-2; TUNEL; MB; MC; SHR; Bioactive peptides; PSA; PSC; AIDS; SIRT6; CIP; BACE1; CAS; CRF; ND; CoVID-19; CuAAC; ROS; Aptamers; EX-4; BAPs; GAPDH; NK; HDMP; Bcl-2; BChE; hMSCs; PCNA; LTM; HTT; LTP; PARP; Next-generation approaches; LDH; PLN; pI; PAC1; Anti-cancer; OBP; SELEX; IP-SELEX; VEGF; PTMs; Mcl-1; PA; Anti-CoVID-19; PEG; PD; Bax; HD; VIP

In preceding years, bioactive peptides (BAPs) have piqued escalating attention owing to their multitudinous biological features. To date, many potential BAPs exhibiting anti-cancer activities have been documented; yet, obstacles such as their safety profiles and consumer acceptance continue to exist...